PHILADELPHIA (August 7, 2018) – Anthony J. Olszanski, MD, RPh, vice chair of the Department of Hematology/Oncology and director of the Early Drug Development Phase 1 Program at Fox Chase Cancer Center, has been named an associate editor of JNCCN—Journal of the National Comprehensive Cancer Network.

PHILADELPHIA (May 19, 2018) – Researchers at Fox Chase Cancer Center are seeking to solve a diagnostic dilemma inherent in current treatment recommendations for bladder cancer. This trial marks the first time the true negative predictive value of a normal cystoscopic evaluation  is being identified, allowing researchers to establish how often bladder cancer hides under the mucosa and evades endoscopic diagnosis. 

PHILADELPHIA (May 15, 2017) – Medical oncologists Lori Goldstein, MD, and Elias Obeid, MD, MPH, are opening a phase 2 immunotherapy clinical trial for newly diagnosed, locally recurrent, or metastatic HER2-overexpressing breast cancer.

PHILADELPHIA (May 25, 2016) — In a study of those patients with advanced non-squamous non-small cell lung cancer (NSCLC), those treated with the drug OPDIVO^® (nivolumab) demonstrated improved overall survival over patients treated with the drug Taxotere^® (docetaxel). 

Immunotherapy has been the most exciting development in bladder cancer treatment in recent years. Its introduction ended a 40-year drought during which no new therapies were available. Unfortunately, many bladder cancers can be resistant to immunotherapy.

Clinical trials play an important role in advancing scientific knowledge and helping shape the care of future cancer patients.

At a time before research on individual genes was possible, the late Nobel Laureate Baruch S. Blumberg combined these approaches, saving millions of lives.

In addition to excellent clinical care, Fox Chase Cancer Center is home to a team of world-renowned cancer researchers who develop and test therapies not available anywhere else. For more than a century, Fox Chase has been a key contributor in advancing understanding of cancer prevention,...